Mid-Atlantic BioTherapeutics is a Clinical-stage Pharmaceutical Company.
Mid-Atlantic BioTherapeutics's investors include SMITM Capital Markets, Legend Innovation Life Science Fund.
Mid-Atlantic BioTherapeutics is headquartered in Doylestown, United States.
Mid-Atlantic BioTherapeutics is a Clinical-stage Pharmaceutical Company.
Mid-Atlantic BioTherapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mid-Atlantic BioTherapeutics — Funding & Investors." VCBacked, August 23, 2025, https://www.vcbacked.co/company/mid-atlantic-biotherapeutics. Accessed August 15, 2026.
VCBacked. (2025). Mid-Atlantic BioTherapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/mid-atlantic-biotherapeutics
{{cite web |title=Mid-Atlantic BioTherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mid-atlantic-biotherapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated